The biggest spender, Johnson & Johnson, shelled out $17.5 billion on sales and marketing in 2013, compared with $8.2 billion for R&D. In the top 10, only Roche spent more on R&D than on sales and marketing.
Most of this marketing money is directed at the physicians who do the prescribing, rather than consumers. As Oliver pointed out, drug companies spent more than $3 billion a year marketing to consumers in the U.S. in 2012, but an estimated $24 billion marketing directly to health care professionals.
"Ask your doctor today if he's taking pharmaceutical company money. Then ask your doctor what the money is for," the narrator says. "Ask your doctor if he's taken any money from the companies who make the drugs he just prescribed for you. Then ask yourself if you're satisfied with that answer."